| cell surface pattern recognition receptor signaling pathway | GO:0002752 | 2 | 0.790 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.677 | |
| innate immune response | GO:0045087 | 157 | 0.656 | |
| defense response to other organism | GO:0098542 | 197 | 0.600 | |
| innate immune response activating signal transduction | GO:0002758 | 50 | 0.555 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.551 | |
| pattern recognition receptor signaling pathway | GO:0002221 | 47 | 0.544 | |
| defense response to virus | GO:0051607 | 68 | 0.529 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.515 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.478 | |
| immune response activating cell surface receptor signaling pathway | GO:0002429 | 72 | 0.474 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.472 | |
| immune response regulating cell surface receptor signaling pathway | GO:0002768 | 80 | 0.434 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.431 | |
| immune effector process | GO:0002252 | 321 | 0.429 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.416 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.414 | |
| activation of immune response | GO:0002253 | 138 | 0.381 | |
| defense response to bacterium | GO:0042742 | 119 | 0.326 | |
| response to molecule of fungal origin | GO:0002238 | 4 | 0.323 | |
| cellular response to lipid | GO:0071396 | 145 | 0.311 | |
| positive regulation of interferon alpha production | GO:0032727 | 4 | 0.306 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.294 | |
| regulation of cell activation | GO:0050865 | 289 | 0.292 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.292 | |
| innate immune response activating cell surface receptor signaling pathway | GO:0002220 | 4 | 0.291 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.284 | |
| adaptive immune response | GO:0002250 | 155 | 0.278 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.266 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.263 | |
| lipopolysaccharide mediated signaling pathway | GO:0031663 | 25 | 0.253 | |
| positive regulation of innate immune response | GO:0045089 | 80 | 0.233 | |
| response to interferon gamma | GO:0034341 | 34 | 0.222 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.216 | |
| stimulatory c type lectin receptor signaling pathway | GO:0002223 | 2 | 0.214 | |
| t cell activation | GO:0042110 | 289 | 0.201 | |
| membrane organization | GO:0061024 | 245 | 0.185 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.178 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.177 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.174 | |
| response to interferon beta | GO:0035456 | 22 | 0.172 | |
| b cell proliferation | GO:0042100 | 53 | 0.172 | |
| cellular response to interferon beta | GO:0035458 | 21 | 0.167 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.164 | |
| regulation of defense response | GO:0031347 | 233 | 0.161 | |
| negative regulation of type i hypersensitivity | GO:0001811 | 1 | 0.160 | |
| cellular response to interferon alpha | GO:0035457 | 4 | 0.158 | |
| interferon beta production | GO:0032608 | 16 | 0.158 | |
| regulation of symbiosis encompassing mutualism through parasitism | GO:0043903 | 52 | 0.155 | |
| positive regulation of cytokine biosynthetic process | GO:0042108 | 40 | 0.154 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.153 | |
| cell killing | GO:0001906 | 67 | 0.151 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.149 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.146 | |
| positive regulation of t cell receptor signaling pathway | GO:0050862 | 4 | 0.144 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.143 | |
| activation of innate immune response | GO:0002218 | 56 | 0.133 | |
| natural killer cell mediated immunity | GO:0002228 | 29 | 0.130 | |
| regulation of ossification | GO:0030278 | 112 | 0.127 | |
| defense response to gram positive bacterium | GO:0050830 | 50 | 0.126 | |
| response to host | GO:0075136 | 3 | 0.118 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.116 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.116 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.112 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.111 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.110 | |
| cytokine production | GO:0001816 | 319 | 0.110 | |
| t cell proliferation | GO:0042098 | 120 | 0.109 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.108 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.107 | |
| leukocyte mediated cytotoxicity | GO:0001909 | 62 | 0.107 | |
| ear development | GO:0043583 | 200 | 0.106 | |
| mapk cascade | GO:0000165 | 281 | 0.103 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.101 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.101 | |
| positive regulation of t cell costimulation | GO:2000525 | 2 | 0.100 | |
| negative regulation of t cell proliferation | GO:0042130 | 38 | 0.096 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.096 | |
| negative regulation of leukocyte proliferation | GO:0070664 | 46 | 0.096 | |
| ossification | GO:0001503 | 216 | 0.095 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.095 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.094 | |
| b cell activation | GO:0042113 | 161 | 0.093 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.090 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.090 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.088 | |
| protein processing | GO:0016485 | 163 | 0.088 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.087 | |
| detection of fungus | GO:0016046 | 2 | 0.087 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.087 | |
| interferon beta biosynthetic process | GO:0045350 | 4 | 0.086 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.086 | |
| regulation of tumor necrosis factor production | GO:0032680 | 49 | 0.086 | |
| regulation of b cell activation | GO:0050864 | 81 | 0.083 | |
| negative regulation of lymphocyte proliferation | GO:0050672 | 45 | 0.082 | |
| chemotaxis | GO:0006935 | 247 | 0.081 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.081 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.081 | |
| negative regulation of viral transcription | GO:0032897 | 3 | 0.078 | |
| cd8 positive alpha beta t cell proliferation | GO:0035740 | 1 | 0.078 | |
| response to type i interferon | GO:0034340 | 12 | 0.077 | |
| toll like receptor 7 signaling pathway | GO:0034154 | 4 | 0.077 | |
| regulation of defense response to virus | GO:0050688 | 18 | 0.074 | |
| viral process | GO:0016032 | 41 | 0.074 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.074 | |
| regulation of protein localization | GO:0032880 | 231 | 0.073 | |
| skin development | GO:0043588 | 220 | 0.072 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.072 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.071 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.069 | |
| eosinophil activation | GO:0043307 | 1 | 0.069 | |
| germ cell development | GO:0007281 | 185 | 0.068 | |
| regulation of defense response to virus by host | GO:0050691 | 8 | 0.068 | |
| type i interferon signaling pathway | GO:0060337 | 10 | 0.067 | |
| regulation of interferon beta production | GO:0032648 | 13 | 0.066 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.066 | |
| regulation of cell motility | GO:2000145 | 236 | 0.065 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.065 | |
| positive regulation of immunological synapse formation | GO:2000522 | 1 | 0.065 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.064 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.064 | |
| jnk cascade | GO:0007254 | 72 | 0.063 | |
| protein maturation | GO:0051604 | 176 | 0.063 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.063 | |
| antigen receptor mediated signaling pathway | GO:0050851 | 64 | 0.062 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.061 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.061 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.060 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.058 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.058 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.058 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.058 | |
| regulation of cytokine biosynthetic process | GO:0042035 | 59 | 0.057 | |
| cellular response to interferon gamma | GO:0071346 | 25 | 0.057 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.057 | |
| extracellular structure organization | GO:0043062 | 148 | 0.056 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.055 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.054 | |
| positive regulation of jnk cascade | GO:0046330 | 46 | 0.054 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.054 | |
| regulation of b cell proliferation | GO:0030888 | 39 | 0.054 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.053 | |
| t cell differentiation | GO:0030217 | 174 | 0.053 | |
| negative regulation of eosinophil degranulation | GO:0043310 | 1 | 0.053 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.053 | |
| t cell receptor signaling pathway | GO:0050852 | 46 | 0.053 | |
| interleukin 18 production | GO:0032621 | 4 | 0.053 | |
| regulation of t cell proliferation | GO:0042129 | 92 | 0.053 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.052 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.051 | |
| dna metabolic process | GO:0006259 | 303 | 0.051 | |
| eosinophil degranulation | GO:0043308 | 1 | 0.051 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.051 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.050 | |
| toll like receptor signaling pathway | GO:0002224 | 38 | 0.050 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.049 | |
| negative regulation of growth | GO:0045926 | 99 | 0.048 | |
| interferon gamma production | GO:0032609 | 67 | 0.048 | |
| nitric oxide metabolic process | GO:0046209 | 25 | 0.048 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.048 | |
| protein catabolic process | GO:0030163 | 221 | 0.048 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.048 | |
| positive regulation of cd8 positive alpha beta t cell extravasation | GO:2000451 | 2 | 0.047 | |
| positive regulation of type i interferon mediated signaling pathway | GO:0060340 | 4 | 0.047 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.046 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.046 | |
| cellular response to molecule of fungal origin | GO:0071226 | 2 | 0.046 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.046 | |
| defense response to protozoan | GO:0042832 | 25 | 0.045 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.045 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.045 | |
| tumor necrosis factor biosynthetic process | GO:0042533 | 10 | 0.045 | |
| negative regulation of toll like receptor signaling pathway | GO:0034122 | 14 | 0.045 | |
| regulation of natural killer cell activation | GO:0032814 | 22 | 0.044 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.044 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.043 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.043 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.043 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.043 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.043 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.043 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.043 | |
| regulation of stress activated mapk cascade | GO:0032872 | 69 | 0.043 | |
| cellular response to type i interferon | GO:0071357 | 10 | 0.043 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.043 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.042 | |
| nitric oxide biosynthetic process | GO:0006809 | 25 | 0.042 | |
| b cell activation involved in immune response | GO:0002312 | 50 | 0.042 | |
| schwann cell proliferation | GO:0014010 | 2 | 0.042 | |
| inflammatory response | GO:0006954 | 244 | 0.041 | |
| positive regulation of t cell extravasation | GO:2000409 | 2 | 0.041 | |
| cytoplasmic pattern recognition receptor signaling pathway | GO:0002753 | 10 | 0.041 | |
| positive regulation of type i interferon production | GO:0032481 | 14 | 0.041 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.041 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.041 | |
| antigen processing and presentation | GO:0019882 | 47 | 0.041 | |
| regulation of t cell costimulation | GO:2000523 | 2 | 0.041 | |
| regulation of cell migration | GO:0030334 | 219 | 0.040 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.040 | |
| endocytosis | GO:0006897 | 168 | 0.040 | |
| phagocytosis | GO:0006909 | 66 | 0.040 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.040 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.039 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.039 | |
| natural killer cell mediated cytotoxicity | GO:0042267 | 29 | 0.039 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.039 | |
| neutrophil migration | GO:1990266 | 37 | 0.039 | |
| positive regulation of platelet activation | GO:0010572 | 5 | 0.039 | |
| regulation of secretion | GO:0051046 | 274 | 0.039 | |
| regulation of jnk cascade | GO:0046328 | 62 | 0.039 | |
| microtubule based process | GO:0007017 | 236 | 0.038 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.038 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.038 | |
| positive regulation of leukocyte mediated cytotoxicity | GO:0001912 | 31 | 0.038 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.038 | |
| regulation of leukocyte mediated cytotoxicity | GO:0001910 | 38 | 0.038 | |
| cell fate commitment | GO:0045165 | 210 | 0.037 | |
| cation transport | GO:0006812 | 399 | 0.037 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.036 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.036 | |
| oligodendrocyte differentiation | GO:0048709 | 53 | 0.036 | |
| negative regulation of viral genome replication | GO:0045071 | 10 | 0.036 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.036 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.036 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.036 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.035 | |
| neuron projection guidance | GO:0097485 | 141 | 0.035 | |
| stem cell differentiation | GO:0048863 | 268 | 0.035 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.034 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.034 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.034 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.034 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.034 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.034 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.034 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.034 | |
| entry into cell of other organism involved in symbiotic interaction | GO:0051806 | 15 | 0.034 | |
| cellular response to bacterial lipopeptide | GO:0071221 | 3 | 0.034 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.034 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.033 | |
| fat cell differentiation | GO:0045444 | 160 | 0.033 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.033 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.033 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.033 | |
| cellular response to peptidoglycan | GO:0071224 | 4 | 0.033 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 47 | 0.033 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.032 | |
| neuron migration | GO:0001764 | 122 | 0.032 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.032 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.032 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.032 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.032 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.032 | |
| alpha beta t cell proliferation | GO:0046633 | 21 | 0.032 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.032 | |
| maintenance of location | GO:0051235 | 89 | 0.032 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.031 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.031 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.031 | |
| wound healing | GO:0042060 | 157 | 0.031 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.031 | |
| macrophage differentiation | GO:0030225 | 20 | 0.031 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.031 | |
| regulation of interferon gamma production | GO:0032649 | 57 | 0.031 | |
| antimicrobial peptide biosynthetic process | GO:0002777 | 2 | 0.031 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.031 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.031 | |
| type i interferon production | GO:0032606 | 29 | 0.031 | |
| positive regulation of osteoblast differentiation | GO:0045669 | 34 | 0.030 | |
| gland development | GO:0048732 | 330 | 0.030 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.030 | |
| osteoclast differentiation | GO:0030316 | 62 | 0.030 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.030 | |
| modulation by symbiont of defense related host nitric oxide production | GO:0052163 | 1 | 0.030 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.030 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.030 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.030 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.030 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.029 | |
| positive regulation of stress activated mapk cascade | GO:0032874 | 48 | 0.029 | |
| negative regulation of myeloid cell differentiation | GO:0045638 | 38 | 0.029 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.029 | |
| regulation of type 2 immune response | GO:0002828 | 18 | 0.029 | |
| regulation of protein binding | GO:0043393 | 60 | 0.029 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.028 | |
| positive regulation of lymphocyte proliferation | GO:0050671 | 70 | 0.028 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.028 | |
| immunoglobulin mediated immune response | GO:0016064 | 69 | 0.028 | |
| regulation of cell killing | GO:0031341 | 40 | 0.028 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.028 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.028 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.028 | |
| positive regulation of coagulation | GO:0050820 | 13 | 0.028 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.028 | |
| regulation of interferon beta biosynthetic process | GO:0045357 | 4 | 0.028 | |
| digestive system development | GO:0055123 | 200 | 0.028 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.028 | |
| natural killer cell activation | GO:0030101 | 44 | 0.028 | |
| positive regulation of ossification | GO:0045778 | 47 | 0.028 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.027 | |
| regulation of antigen receptor mediated signaling pathway | GO:0050854 | 29 | 0.027 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.027 | |
| viral transcription | GO:0019083 | 3 | 0.027 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.027 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.027 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.027 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.026 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.026 | |
| response to oxygen levels | GO:0070482 | 62 | 0.026 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.026 | |
| positive regulation of interleukin 18 production | GO:0032741 | 2 | 0.026 | |
| positive regulation of hematopoietic stem cell migration | GO:2000473 | 1 | 0.026 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.026 | |
| viral gene expression | GO:0019080 | 3 | 0.026 | |
| regulation of interleukin 4 biosynthetic process | GO:0045402 | 3 | 0.026 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.026 | |
| toxin transport | GO:1901998 | 38 | 0.026 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.026 | |
| regulation of protein processing | GO:0070613 | 96 | 0.026 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.026 | |
| regulation of nlrp3 inflammasome complex assembly | GO:1900225 | 4 | 0.026 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.026 | |
| helper t cell chemotaxis | GO:0035704 | 1 | 0.026 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.025 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.025 | |
| negative regulation of macrophage apoptotic process | GO:2000110 | 3 | 0.025 | |
| t cell activation involved in immune response | GO:0002286 | 43 | 0.025 | |
| glial cell differentiation | GO:0010001 | 131 | 0.025 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.025 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.025 | |
| positive regulation of protein secretion | GO:0050714 | 52 | 0.025 | |
| positive regulation by symbiont of defense related host nitric oxide production | GO:0052347 | 1 | 0.025 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.025 | |
| viral life cycle | GO:0019058 | 36 | 0.025 | |
| regulation of protein transport | GO:0051223 | 163 | 0.025 | |
| t helper 17 cell chemotaxis | GO:0035705 | 1 | 0.025 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.025 | |
| positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation | GO:2000526 | 1 | 0.024 | |
| regulation of gliogenesis | GO:0014013 | 50 | 0.024 | |
| mast cell proliferation | GO:0070662 | 4 | 0.024 | |
| regulation of blood coagulation | GO:0030193 | 28 | 0.024 | |
| regulation of nitric oxide biosynthetic process | GO:0045428 | 18 | 0.024 | |
| negative regulation of nlrp3 inflammasome complex assembly | GO:1900226 | 2 | 0.024 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.024 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.024 | |
| regulation of cd8 positive alpha beta t cell proliferation | GO:2000564 | 1 | 0.024 | |
| cytokine biosynthetic process | GO:0042089 | 68 | 0.024 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.024 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.024 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.024 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.024 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.024 | |
| regulation of chemokine production | GO:0032642 | 30 | 0.024 | |
| leukocyte chemotaxis | GO:0030595 | 69 | 0.024 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.024 | |
| negative regulation of hypersensitivity | GO:0002884 | 3 | 0.024 | |
| myeloid dendritic cell differentiation | GO:0043011 | 16 | 0.024 | |
| digestive tract development | GO:0048565 | 190 | 0.024 | |
| positive regulation of b cell activation | GO:0050871 | 49 | 0.023 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.023 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.023 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.023 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.023 | |
| membrane fusion | GO:0061025 | 38 | 0.023 | |
| regulation of defense response to bacterium | GO:1900424 | 3 | 0.023 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.023 | |
| positive regulation of natural killer cell mediated cytotoxicity | GO:0045954 | 16 | 0.023 | |
| tissue remodeling | GO:0048771 | 102 | 0.023 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 49 | 0.023 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.023 | |
| regulation of interferon alpha production | GO:0032647 | 5 | 0.023 | |
| positive regulation of b cell proliferation | GO:0030890 | 24 | 0.022 | |
| response to alcohol | GO:0097305 | 48 | 0.022 | |
| regulation of binding | GO:0051098 | 111 | 0.022 | |
| detection of stimulus | GO:0051606 | 84 | 0.022 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.022 | |
| regulation of granulocyte chemotaxis | GO:0071622 | 17 | 0.022 | |
| kidney development | GO:0001822 | 213 | 0.022 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.022 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.022 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.022 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.022 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.021 | |
| tissue homeostasis | GO:0001894 | 115 | 0.021 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.021 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.021 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.021 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.021 | |
| microglial cell activation | GO:0001774 | 3 | 0.021 | |
| positive regulation of nucleotide binding oligomerization domain containing 2 signaling pathway | GO:0070434 | 2 | 0.021 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.021 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.021 | |
| angiogenesis | GO:0001525 | 201 | 0.021 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.021 | |
| stem cell development | GO:0048864 | 219 | 0.021 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.021 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.021 | |
| positive regulation of interferon beta biosynthetic process | GO:0045359 | 3 | 0.021 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.021 | |
| negative regulation of b cell proliferation | GO:0030889 | 13 | 0.021 | |
| regulation of platelet activation | GO:0010543 | 17 | 0.021 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.021 | |
| regulation of osteoclast differentiation | GO:0045670 | 36 | 0.021 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.021 | |
| cd8 positive alpha beta t cell extravasation | GO:0035697 | 3 | 0.021 | |
| protein localization to organelle | GO:0033365 | 185 | 0.021 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.021 | |
| response to growth factor | GO:0070848 | 198 | 0.020 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.020 | |
| myd88 dependent toll like receptor signaling pathway | GO:0002755 | 7 | 0.020 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.020 | |
| intestinal epithelial structure maintenance | GO:0060729 | 4 | 0.020 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.020 | |
| mast cell activation | GO:0045576 | 27 | 0.020 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.020 | |
| regulation of immunoglobulin mediated immune response | GO:0002889 | 37 | 0.020 | |
| compound eye development | GO:0048749 | 1 | 0.020 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.020 | |
| epidermis development | GO:0008544 | 187 | 0.020 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.020 | |
| regulation of interleukin 6 production | GO:0032675 | 55 | 0.020 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.020 | |
| cellularization | GO:0007349 | 1 | 0.020 | |
| induction by organism of immune response of other organism involved in symbiotic interaction | GO:0052558 | 1 | 0.020 | |
| negative regulation of leukocyte differentiation | GO:1902106 | 51 | 0.020 | |
| regulation of toll like receptor signaling pathway | GO:0034121 | 20 | 0.020 | |
| regulation of nucleotide binding oligomerization domain containing 1 signaling pathway | GO:0070428 | 3 | 0.020 | |
| muscle tissue development | GO:0060537 | 308 | 0.020 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.019 | |
| regulation of t cell differentiation | GO:0045580 | 83 | 0.019 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.019 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.019 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.019 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.019 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.019 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.019 | |
| cognition | GO:0050890 | 149 | 0.019 | |
| negative regulation of cysteine type endopeptidase activity | GO:2000117 | 22 | 0.019 | |
| regulation of antimicrobial humoral response | GO:0002759 | 3 | 0.019 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.019 | |
| actin filament organization | GO:0007015 | 113 | 0.019 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.019 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.019 | |
| autophagy | GO:0006914 | 45 | 0.019 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.019 | |
| branching involved in mammary gland duct morphogenesis | GO:0060444 | 27 | 0.019 | |
| regulation of dendritic cell chemotaxis | GO:2000508 | 1 | 0.019 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.019 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.019 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.019 | |
| positive regulation of actin nucleation | GO:0051127 | 3 | 0.019 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.019 | |
| positive regulation of adaptive immune response | GO:0002821 | 61 | 0.018 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.018 | |
| type i interferon biosynthetic process | GO:0045351 | 9 | 0.018 | |
| regulation of t cell extravasation | GO:2000407 | 3 | 0.018 | |
| positive regulation of endopeptidase activity | GO:0010950 | 43 | 0.018 | |
| regulation of response to biotic stimulus | GO:0002831 | 38 | 0.018 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.018 | |
| regulation of toll like receptor 9 signaling pathway | GO:0034163 | 3 | 0.018 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.018 | |
| positive regulation of protein complex assembly | GO:0031334 | 45 | 0.018 | |
| hair follicle cell proliferation | GO:0071335 | 3 | 0.018 | |
| gliogenesis | GO:0042063 | 141 | 0.018 | |
| chemokine mediated signaling pathway | GO:0070098 | 17 | 0.018 | |
| tumor necrosis factor superfamily cytokine production | GO:0071706 | 51 | 0.018 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.018 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.018 | |
| immunoglobulin production | GO:0002377 | 73 | 0.018 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.018 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.018 | |
| positive regulation of hemostasis | GO:1900048 | 10 | 0.018 | |
| modulation by symbiont of host defense response | GO:0052031 | 1 | 0.018 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.018 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.018 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.018 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.018 | |
| positive regulation of granulocyte macrophage colony stimulating factor biosynthetic process | GO:0045425 | 2 | 0.018 | |
| actin filament bundle assembly | GO:0051017 | 40 | 0.018 | |
| single organism nuclear import | GO:1902593 | 95 | 0.018 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.018 | |
| negative regulation of homeostatic process | GO:0032845 | 71 | 0.018 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.018 | |
| peptide transport | GO:0015833 | 133 | 0.017 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.017 | |
| positive regulation by symbiont of host defense response | GO:0052509 | 1 | 0.017 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.017 | |
| response to immune response of other organism involved in symbiotic interaction | GO:0052564 | 3 | 0.017 | |
| regulation of exocytosis | GO:0017157 | 61 | 0.017 | |
| pyrimidine containing compound catabolic process | GO:0072529 | 3 | 0.017 | |
| necrotic cell death | GO:0070265 | 30 | 0.017 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.017 | |
